Featured Research

from universities, journals, and other organizations

Dietary supplement linked to increased muscle mass in the elderly

Date:
June 17, 2013
Source:
Endocrine Society
Summary:
A supplemental beverage used to treat muscle-wasting may help boost muscle mass among the elderly, according to a new study.

A supplemental beverage used to treat muscle-wasting may help boost muscle mass among the elderly, according to a new study. The results were presented today at The Endocrine Society's 95th Annual Meeting in San Francisco.

The supplemental beverage, called Juven®, contains three amino acids, including arginine. Amino acids are the building blocks of proteins, and are required for cell growth and repair. The amino acid arginine is especially important because it increases growth-hormone production, which causes the body to produce a critical protein called insulin-like growth factor 1, or IGF-1. This protein promotes growth and development and, as its name suggests, is similar in structure to the hormone insulin.

Previously, studies showed that Juven® helped increase muscle mass in patients with AIDS or cancer. These earlier findings led this study's investigators to hypothesize that the increased muscle mass could result from greater blood concentrations of IGF-1. They theorized that these increased protein levels could have the same benefits among the elderly, who also experience decreased muscle mass and strength related to drops in hormone production that occur with aging. In turn, increased muscle strength could potentially improve quality of life among the elderly.

They found that participants who received Juven® had significant increases in lean body mass, while those who received placebo did not have any change. In addition, blood concentrations of IGF-1 increased among Juven® recipients, but not among the placebo group. The correlation between the improved IGF-1 concentrations and increased lean tissue, however, was not statistically significant.

"The amino acid cocktail of the dietary supplement Juven® appears to hold promise for increasing lean body in healthy older adults," said study lead author Amy C. Ellis, PhD, assistant professor at the University of Alabama at Tuscaloosa. "However, more research is needed to determine the cause-and-effect relationship and the mechanisms by which the amino acids in Juven® may favorably affect body composition of healthy, older adults."

Study participants were 29 healthy adults between the ages of 65 and 87 years. Each received either Juven® or a placebo drink twice a day, along with their regular daily diet, for six months. At the beginning of the study and again six months later, investigators used a special test to measure lean body mass. At both times, they also assessed participants' blood levels of IGF-1 after fasting.

The National Institutes of Health and the Center for Aging at the University of Alabama-Birmingham funded the study. Abbott Laboratories, the manufacturer of Juven®, provided the dietary supplement and the placebo.


Story Source:

The above story is based on materials provided by Endocrine Society. Note: Materials may be edited for content and length.


Cite This Page:

Endocrine Society. "Dietary supplement linked to increased muscle mass in the elderly." ScienceDaily. ScienceDaily, 17 June 2013. <www.sciencedaily.com/releases/2013/06/130617110823.htm>.
Endocrine Society. (2013, June 17). Dietary supplement linked to increased muscle mass in the elderly. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2013/06/130617110823.htm
Endocrine Society. "Dietary supplement linked to increased muscle mass in the elderly." ScienceDaily. www.sciencedaily.com/releases/2013/06/130617110823.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) — The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) — Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) — America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) — China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:  

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile iPhone Android Web
          Follow Facebook Twitter Google+
          Subscribe RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins